Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of the Anti Hepatitis B Placenta Transfer Factor Injection in the Treatment of HBeAg Positive Chronic Hepatitis B, Randomized, Double Blind, Placebo Controlled, Multi Center Clinical Trial

NCT02412319 is registered in ClinicalTrials.gov with Shineway Pharmaceutical Co.,Ltd as lead sponsor.

NCT NCT02412319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02412319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of the Anti Hepatitis B Placenta Transfer Factor Injection in the Treatment of HBeAg Positive Chronic Hepatitis B, Randomized, Double Blind, Placebo Controlled, Multi Center Clinical Trial
Lead sponsor
Shineway Pharmaceutical Co.,Ltd
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2014
Completion date
December 31, 2017
Enrollment
288 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hbeag positive chronic hepatitis b